Multiplex Assays Market: By Type (Cell-based Multiplex Assays, Protein Multiplex Assays, and Nucleic Acid Multiplex Assays), End-user (Hospital & Clinics, Research Institutions, Pharmaceutical & Biotechnology Companies, and Diagnostic Laboratories), and Geography

Purchase Option

$ 4400
$ 6600
$ 8900

Multiplex Assay Market size is estimated to value USD 3.9 billion in 2023 representing a compound annual growth rate (CAGR) of 9.1%. The factors that contribute to the growth of the market, are the increase in the prevalence of chronic & infectious diseases such as respiratory infections, sexually transmitted infections, gastrointestinal infections, and others. Also, the covid-19 impacted market growth raising awareness of early diagnosis, and advantages over the singleplex & traditional assay, as multiplex assay is used to measure the multiple biomarkers to tailor the treatment for personalized medicine, and detection of multiple pathogens in an automated process, which became more efficient & cost-effective. Further, demand for multiplex assay for R&D from research institutions, and pharmaceutical & biotechnology companies, is expected to boost market growth over the forecast period. Despite the promising growth prospects, the global multiplex assay market also faces certain challenges with limited resources like high investment costs, lack of skilled personnel for data analysis, and regulatory hurdles.

Multiplex Assay Market Key Developments:
  • In February 2024, Luminex Corporation launched the xMAP® UltraPlex™ II Multiplex Bead Array System, which is designed for high-throughput multiplex assays.
  • In January 2024, Qiagen announced the opening of a new application center in Research Triangle Park, North Carolina, which will focus on developing and supporting next-generation sequencing (NGS) and multiplex assay technologies.

Multiplex Assays Market Summary

Study Period

2024-30

Base Year

2023

CAGR

9.1%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Multiplex Assays Market Dynamics

The rising demand for accurate & efficient, and reduced sample volume requirements, will attract multiplex assays over traditional single-plex assays for the detection of infectious diseases, and monitoring of chronic diseases such as cancer, diabetes, and autoimmune disorders at early stages, with technological advancements for developing the new assay platforms and biomarkers for the continuously improving the speed of these assay to increase R&D activities and also to develop the personalized medicines. Emerging markets, such as Asia Pacific and Latin America, are expected to present significant growth opportunities due to rising healthcare expenditure, increasing awareness of advanced diagnostics, and growing government support for healthcare infrastructure development.

Key Features of the Reports

  • The multiplex assays market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Multiplex Assays Market Segmentation

By Type
  • Cell-based Multiplex Assays
  • Protein Multiplex Assays
  • Nucleic Acid Multiplex Assays
By End User
  • Hospital & Clinics
  • Research Institutions
  • Pharmaceutical & Biotechnology Companies
  • Diagnostic Laboratories
By Geography
  • North America
  • Europe
  • The Asia Pacific
  • Latin America
  • MEA

Frequently Asked Questions

The global multiplex assay market size i s estimated to value USD 3.9 billion in 2023 representing a compound annual growth rate (CAGR) of 9.1%.

Fisher Scientific Inc, Illumina Inc, Bio Rad Laboratories Inc, Qiagen, Abcam plc,

Asia-Pacific is the fastest growing and North America is the dominant market in global multiplex assay market

1.Executive Summary
2.Global Multiplex Assays Market Introduction 
2.1.Global Multiplex Assays Market  - Taxonomy
2.2.Global Multiplex Assays Market  - Definitions
2.2.1.Type 
2.2.2.End User
2.2.3.Region
3.Global Multiplex Assays Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Multiplex Assays Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Multiplex Assays Market  By Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Cell-based Multiplex Assays
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Protein Multiplex Assays
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Nucleic Acid Multiplex Assays
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6.Global Multiplex Assays Market  By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Hospital & Clinics
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Research Institutions
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Pharmaceutical & Biotechnology Companies
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Diagnostic Laboratories
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
7.Global Multiplex Assays Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. North America
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Europe
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Asia Pacific (APAC)
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Middle East and Africa (MEA)
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Latin America
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8.North America Multiplex Assays Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Type  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.1.1.Cell-based Multiplex Assays
8.1.2.Protein Multiplex Assays
8.1.3.Nucleic Acid Multiplex Assays
8.2.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.2.1.Hospital & Clinics
8.2.2.Research Institutions
8.2.3.Pharmaceutical & Biotechnology Companies
8.2.4.Diagnostic Laboratories
8.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.3.1.United States of America (USA)
8.3.2.Canada
9.Europe Multiplex Assays Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Cell-based Multiplex Assays
9.1.2.Protein Multiplex Assays
9.1.3.Nucleic Acid Multiplex Assays
9.2.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Hospital & Clinics
9.2.2.Research Institutions
9.2.3.Pharmaceutical & Biotechnology Companies
9.2.4.Diagnostic Laboratories
9.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Germany
9.3.2.France
9.3.3.Italy
9.3.4.United Kingdom (UK)
9.3.5.Spain
10.Asia Pacific (APAC) Multiplex Assays Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Cell-based Multiplex Assays
10.1.2.Protein Multiplex Assays
10.1.3.Nucleic Acid Multiplex Assays
10.2.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Hospital & Clinics
10.2.2.Research Institutions
10.2.3.Pharmaceutical & Biotechnology Companies
10.2.4.Diagnostic Laboratories
10.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.China
10.3.2.India
10.3.3.Australia and New Zealand (ANZ)
10.3.4.Japan
10.3.5.Rest of APAC
11.Middle East and Africa (MEA) Multiplex Assays Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Cell-based Multiplex Assays
11.1.2.Protein Multiplex Assays
11.1.3.Nucleic Acid Multiplex Assays
11.2.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Hospital & Clinics
11.2.2.Research Institutions
11.2.3.Pharmaceutical & Biotechnology Companies
11.2.4.Diagnostic Laboratories
11.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.GCC Countries
11.3.2.South Africa
11.3.3.Rest of MEA
12.Latin America Multiplex Assays Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Cell-based Multiplex Assays
12.1.2.Protein Multiplex Assays
12.1.3.Nucleic Acid Multiplex Assays
12.2.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Hospital & Clinics
12.2.2.Research Institutions
12.2.3.Pharmaceutical & Biotechnology Companies
12.2.4.Diagnostic Laboratories
12.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Brazil
12.3.2.Mexico
12.3.3.Rest of LA
13. Competition Landscape
13.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
13.2.1.Luminex Corporation - A Diasorin Company (US)
13.2.2.Thermo Fisher Scientific (US)
13.2.3.Illumina (US)
13.2.4.Bio-Rad laboratories
13.2.5.QIAGEN (Netherlands)
13.2.6.Merck KGaA (Germany)
13.2.7.Agilent Technologies
13.2.8.MESO SCALE DIAGNOSTICS, LLC.
13.2.9.RANDOX LABORATORIES LIMITED
13.2.10.BioTechne
13.2.11.Olink Proteomics (Sweden)
13.2.12.Diasorin S.p.A. (Italy)
13.2.13.BD(US)
13.2.14.Abcam plc (UK)
14. Research Methodology 
15. Appendix and Abbreviations 
  • Luminex Corporation - A Diasorin Company (US)
  • Thermo Fisher Scientific (US)
  • Illumina (US)
  • Bio-Rad laboratories
  • QIAGEN (Netherlands)
  • Merck KGaA (Germany)
  • Agilent Technologies
  • MESO SCALE DIAGNOSTICS, LLC.
  • RANDOX LABORATORIES LIMITED
  • BioTechne
  • Olink Proteomics (Sweden)
  • Diasorin S.p.A. (Italy)
  • BD(US)
  • Abcam plc (UK)

Adjacent Markets